Molecular Blood Typing, Grouping & Infectious Disease NAT Marketplace Examined by VPG in Its Discounted Report Published at

20 Dec 2017 • by Natalie Aster

LONDON – Worldwide, the market for molecular blood typing, grouping and infectious disease nucleic acid testing (NAT) is seeing fast-paced momentum. The market has an enormous scope owing to the surging demand for blood transfusion worldwide. When it comes to transfusion, the compatibility of the blood of the donor with that of the recipient’s is very important. Thus, before blood transfusion, to inspect compatibility, blood samples are cross matched with one another. Transfusion of blood is generally safe; although, allogenic immunisation can cause complications in the recipients, specifically those having sicklemia.

Factors like soaring demand, enhanced government interventions have boosted the growth of the market. Meantime, limiting factors such as logistical and administrative challenges, sluggish turnaround, expensiveness, demand for high priced equipment and improper information systems for managing the results. Due to these facts, the market observes a hike in the need for molecular typing tests. The uptake of molecular testing in blood transfusion processes has diminished the challenges to a great degree.

Discounted research report “Global Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2017-2021” created by VPG evaluates the main business opportunities in the world molecular blood banking marketplace across the USA, Europe (France, Germany, Spain, Italy, and the UK), and Japan.

The report gives a granular overview of the worldwide market examining the structure of the sector, business environment, market sizing and growth. It presents insights into the major product development opportunities, discusses variant market penetration strategies, and sheds light on the likely barriers to market entry and associated risks. The study provides a detailed assessment of the technology and market, covering key blood typing, grouping and infectious disease screening tests; provides a detailed instrumentation review; give details about key blood banking technologies and their prospective applications. For each of the country markets, the report provides insights into the market structure; analyses the market size, test volume and sales projections, based on market segment; covers top suppliers’ market shares and sales. Furthermore, the report profiles the dominant and emerging competitors; and pinpoints specific product and market opportunities suppliers are set to face in the next 5 years.

Many other discounted and new studies by this publisher are available in VPG online catalogue at


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970